Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Nagashima, Makoto

Class:IdPerson:3215217
_displayNameNagashima, Makoto
_timestamp2013-03-15 15:08:15
created[InstanceEdit:3215206] Orlic-Milacic, M, 2013-03-15
firstnameMakoto
initialM
surnameNagashima
(author)[LiteratureReference:3215174] p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity
[LiteratureReference:3215193] A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis
[LiteratureReference:3215218] ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation
[LiteratureReference:3654162] Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers
[Change default viewing format]
No pathways have been reviewed or authored by Nagashima, Makoto (3215217)